Israel Englander Cogent Biosciences, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 103,400 shares of COGT stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,400

Previous 78,500 31.72%

Holding current value

$1.13 Million

Previous $527,000 65.28%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.01 - $9.04 $6.76 Million - $10.2 Million	-1,124,069 Reduced 47.71%	1,231,857 $10.4 Million
Q1 2024 May 15, 2024	SELL	$4.38 - $9.02 $1.93 Million - $3.98 Million	-441,318 Reduced 15.78%	2,355,926 $15.8 Million
Q4 2023 Feb 14, 2024	BUY	$4.06 - $10.08 $8.84 Million - $21.9 Million	2,177,228 Added 351.16%	2,797,244 $16.4 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $5.92 Million - $7.95 Million	600,774 Added 3122.2%	620,016 $7.34 Million
Q1 2023 May 15, 2023	SELL	$10.04 - $15.5 $1.82 Million - $2.8 Million	-180,940 Reduced 90.39%	19,242 $208,000
Q4 2022 Feb 14, 2023	BUY	$10.65 - $14.84 $2.13 Million - $2.97 Million	200,182 New	200,182 $2.31 Million
Q2 2022 Aug 15, 2022	BUY	$3.92 - $9.73 $1.61 Million - $4.01 Million	411,773 Added 1148.25%	447,634 $4.04 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.7 $76,007 - $124,531	-14,314 Reduced 28.53%	35,861 $269,000
Q4 2021 Feb 14, 2022	BUY	$7.51 - $10.81 $376,814 - $542,391	50,175 New	50,175 $431,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $9.3 $5.99 Million - $7.13 Million	-766,326 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $5.38 Million - $8.89 Million	720,323 Added 1565.82%	766,326 $6.73 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $415,867 - $598,499	46,003 New	46,003 $517,000

Others Institutions Holding COGT

# of Institutions

159

Shares Held

114M

Call Options Held

104K

Put Options Held

163K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $717M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account